McAdam, A. J., A. N. Schweitzer, et al . (1998). "The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells." Immunol Rev 165: 231- 47. 130. McGuire, W. P. (2009). "Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates." J Clin Oncol 27(28): 4633-4. 131. McMahon, S., M. H. Laprise, et al. ( 2003). "Alternative pathway for the role of furin in tumor cell invasion process. E nhanced MMP-2 levels through bioactive TGFbeta." Exp Cell Res 291(2): 326-39. 132. Mei, L., H. Chen, et al. "Maintenanc e chemotherapy for ovarian cancer." Cochrane Database Syst Rev 9: CD007414. 133. Merzak, A., S. McCrea, et al. (1994) . "Control of human glioma cell growth, migration and invasion in vi tro by transforming growth fa ctor beta 1." Br J Cancer 70(2): 199-203. 134. Murray N, E. R., Nemunaitis J (2010) . Lung Cancer Vaccines. Principles and Practice of Lung Cancer: The Official Re ference Text of the IASLC. C. D. Lippincott Williams and Wilkins; Pass H, Johnson D, Minna J, Turrisi A, Scagliotti G, The International Associati on for the Study of Lung Cancer : 753-766. 135. Murtaza, A., V. K. Ku chroo, et al. (1999). "Changes in the strength of co- stimulation through the B7/C D28 pathway alter functional T cell responses to altered peptide liga nds." Int Immunol 11(3): 407-16. 136. Naganuma, H., A. Sasaki, et al. (1996). "Transforming growth factor-beta inhibits interferon-gamma secretion by lymphokine- activated killer ce lls stimulated with tumor cells." Neurol Med Chir (Tokyo) 36(11): 789-95. Protocol # CL-PTL 105 CONFIDENTIAL AM #9 09/25/15 Page 88 137. Napoletano, C., F. Bella ti, et al. (2009). "Ovarian C ancer Cytoreduction Induces Changes in T Cell Population Subsets Reducing Immunosuppression." J Cell Mol Med. 138. Napoletano, C., F. Bella ti, et al. (2010). "Ovarian ca ncer cytoreduction induces changes in T cell population subsets reducing immunosuppression." J Cell Mol Med 14(12): 2748-59. 139.